facebook
twitter
rss
account
search
search
 

FDA calls for expanded Byetta precautions

Oct. 16, 2007 at 3:45 PM   |   Comments

WASHINGTON, Oct. 16 (UPI) -- The U.S. Food and Drug Administration announced it suspects a link between usage of Byetta, a type 2 diabetes drug, and acute pancreatitis.

The FDA said it reviewed 30 reports of acute pancreatitis in patients taking Byetta (exenatide) and said, "An association between Byetta and acute pancreatitis is suspected in some of these cases."

Officials said the maker of Byetta, Amylin Pharmaceuticals Inc., has agreed to include information about acute pancreatitis in the precautions section of the product's label.

"Healthcare professionals should be alert to the signs and symptoms of acute pancreatitis and instruct patients taking Byetta to seek prompt medical care if they experience unexplained, persistent, severe abdominal pain which may or may not be accompanied by vomiting," the FDA said.

© 2007 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
6,000-year-old temple discovered in prehistoric Ukraine settlement 6,000-year-old temple discovered in prehistoric Ukraine settlement
2
An ancient tsunami wrecked Hawaii; it could happen again An ancient tsunami wrecked Hawaii; it could happen again
3
NASA orbiter beams back images of Siding Spring comet NASA orbiter beams back images of Siding Spring comet
4
DC drone hobbyists in limbo over flying locations DC drone hobbyists in limbo over flying locations
5
Protestors object plans to build telescope on land sacred to native Hawaiians Protestors object plans to build telescope on land sacred to native Hawaiians
Trending News
Around the Web
x
Feedback